Multimorbidity, Drug Combinations, Spike Epitopes and Fast Testing as Central Factors in COVID-19 Treatments

Abstract

Since December 2019 almost 20 million infected and 1000,000 deaths. Today we hear the at the USA president Mr. Donald Trump (age 74) has contracted the corona disease. The Hard acute breathing Distress Syndrome (SARS-CoV-2) has been reported worldwide. Even though Coronary artery disease (COVID-19) Respiratory complications Were the most common and life-threatening, there Frequent reports of central and peripheral nervous system (PNS) involvement. It was thought that the elderly are more vulnerable to the disease, which turns out as wrong.